The issue with traditional type 2 diabetes treatment
Type 2 diabetes, also known as “adult-onset diabetes,” is the most prevalent type. 90% of people suffering from this blood sugar condition have type 2. When blood glucose levels begin to rise (e.g. after we eat), cells in the pancreas called beta cells quickly respond by releasing insulin, a hormone that tells cells in the body to take up glucose from the blood. In type 2 diabetes, there is beta cell inflammation and losses in the cells’ maturity and ability to produce insulin, or your body’s cell become resistant to insulin. Symptoms include increased thirst, frequent urination, hunger, fatigue, and blurred vision. Type 2 diabetes is progressive and tends to get worse with age.

Overweight people are at a higher risk of developing this type of diabetes because the body releases chemicals that destabilize the metabolic and cardiovascular systems. Age is also a risk factor, as is orientation with African, South Asian and Middle Eastern descents. Managing type 2 diabetes involves losing weight, exercise, eating healthy and most importantly, monitoring blood sugar levels. Since this is a progressive disease, the patient may eventually need to take insulin to manage the blood sugar.

How stem cells help with type-2 diabetes
There is no known cure for diabetes, but stem cells therapy is producing promising results. In six systematic reviews and meta-analyses of studies in patients with type 1 and type 2 diabetes, the reported positive findings of stem cell therapy were improved glycosylated hemoglobin and C-peptide levels and insulin requirements. Studies conducted in India showed that stem cells could reduce the insulin dose taken by type 2 diabetes patients.

For type 2 diabetes patients, the effects of stem cell therapy can lead to a reduction in harmful symptoms, stabilization of condition, and significant quality of life improvement.

*Typical Treatment Protocol
A typical protocol consists of intravenous transplant of 100+ million cord tissue-derived MSCs (Mesenchymal Stem Cells). The procedure takes approximately 45 minutes. The protocol is minimally invasive to the patient and has very little downtime. Patients normally travel home two days following their scheduled appointment.

Treatment goals
The primary goal of our protocol is the marked reduction in the levels of chronic low-grade inflammation for an extended period of time.

Stem cells are uniquely and intrinsically able to migrate to sites of damage and inflammation in the body. Studies have shown that stem cells are able to orchestrate the repair and regeneration of deteriorated tissues, as well as modulate the immune system, to promote better health.

The benefits of stem cell therapy can include a reduction in harmful symptoms, the slowing of the progression of the disease, and an overall increase in quality of life.

*Treatment protocols are individualized for each patient according to a variety of factors, including overall patient health, condition, and severity. A protocol optimized for your particular situation will be developed in consultation with a stem cell physician and a review of your medical records.